PB
Pacific Biosciences of California
🇺🇸XNAS.PACBUnited StatesHealthcare
$1.38USDup +0.03 (+2.22%)OpenEnd of day5:39 PM
Price$1.38+0.03 (+2.22%)
Profile
- Healthcare
- Medical Devices
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US69404D1081
- CUSIP
- 69404D108
Company
- Employees
- 485
- Headquarters
- Menlo Park, United States
- Website
- https://www.pacb.com
- CEO
- Mr. Mark Van Oene Ph.D.
Market
- Shares outstanding
- 310.8M
- Market cap
- $428.95M
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- $428.95M
- EPS LTM
- -$0.42
- P/E LTM
- -3.97
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $159.27M+2.02%up year on year
- Net income
- -$131.39M+75.04%up year on year
- Gross margin
- 35.97%+68.27%up year on year
- Free cash flow
- -$171.16M-8.8%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.